SEC Form 4 · accession 0001209191-17-045214
GYRE THERAPEUTICS, INC. · GYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Augustine Lawlor
Director
Period of report
Jul 13, 2017
Accepted (ET)
Jul 14, 2017 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124105
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.40 | Jul 13, 2017 | A | 10,000 | A | Jun 15, 2018 | Jul 13, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option shall vest monthly over a period of 12 months commencing June 15, 2017.